VIOS Fertility Institute Chicago is a full-service reproductive medicine clinic located in Chicago, Illinois, offering evidence-based fertility evaluation and treatment for individuals and couples. As part of the VIOS Fertility network, the Chicago location benefits from shared clinical protocols and laboratory standards developed across multiple sites. Illinois is one of the strongest mandate states for fertility insurance coverage in the United States, making VIOS a meaningful option for patients who hold qualifying insurance plans. For a broader look at fertility providers across the state, visit our Illinois fertility clinics directory.
Physicians and Clinical Team
VIOS Fertility Institute Chicago is led by reproductive endocrinologists who are board-certified by the American Board of Obstetrics and Gynecology with subspecialty certification in reproductive endocrinology and infertility. The network's physicians have published research in peer-reviewed journals and contribute to advancing clinical practice in areas such as ovarian stimulation, embryo culture, and preimplantation genetic testing. The care team includes reproductive nurses, certified embryologists, sonographers, and patient financial counselors who work in coordination to provide seamless care from diagnosis through delivery.
Services and Treatments
VIOS Fertility Institute Chicago offers a wide spectrum of reproductive services:
- Fertility evaluation — comprehensive diagnostic bloodwork, antral follicle count, semen analysis, and uterine cavity assessment
- Ovulation induction with monitoring — for patients with ovulatory dysfunction
- Intrauterine insemination (IUI) — a first-line treatment for mild male factor, cervical factor, and unexplained infertility
- In vitro fertilization (IVF) — conventional stimulation and minimal stimulation protocols
- Intracytoplasmic sperm injection (ICSI)
- Preimplantation genetic testing for aneuploidies (PGT-A) — to select euploid embryos for transfer
- Preimplantation genetic testing for monogenic disorders (PGT-M)
- Frozen embryo transfer (FET)
- Egg and embryo cryopreservation — fertility preservation for medical or elective indications
- Third-party reproduction — donor egg, donor sperm, and gestational carrier coordination
- Male fertility evaluation and treatment — including surgical sperm retrieval
Laboratory and Success Rates
VIOS Fertility Institute invests heavily in embryology laboratory infrastructure. Embryologists use time-lapse imaging systems and precise incubator conditions to monitor embryo development without disturbing culture. Extended blastocyst culture and vitrification-based cryopreservation are standard protocols. The clinic participates in quality benchmarking against national averages.
Patients should review the most current cycle-level data published by the CDC's ART Surveillance program and the SART Clinic Summary Report.
Patient Experience
Patients at VIOS Fertility Institute Chicago report a high degree of involvement from their care team throughout treatment. The clinic's Chicago location is accessible via public transit and serves a diverse patient population from across the metropolitan area, including Cook, DuPage, Lake, and Will counties. VIOS emphasizes individualized care plans and maintains a philosophy of transparency around treatment costs, timelines, and realistic expectations. Nursing staff and coordinators are available to answer questions promptly, which many patients find critical to managing the stress of fertility treatment.
Considering At-Home Insemination?
Not every fertility journey begins in a clinic. For individuals and couples exploring their options before pursuing formal medical treatment — or those working with a known sperm donor — at-home insemination kits offer a private, lower-cost first step. MakeAMom offers FDA-cleared at-home insemination systems designed for a variety of needs: the CryoBaby kit works with frozen or low-volume sperm, the Impregnator kit is optimized for low motility sperm, and the BabyMaker kit is designed for users with sensitivities or conditions such as vaginismus. All kits are reusable and shipped in plain, discreet packaging. MakeAMom reports an average 67% success rate among clients who use their home insemination systems. At-home insemination is not a replacement for medical care when underlying conditions are present, but it can be a meaningful starting point — and knowing when to consult a board-certified reproductive endocrinologist is the right next step.
Insurance and Financing
Illinois has one of the most comprehensive fertility insurance mandates in the country. Illinois law requires most group health insurance plans to cover the diagnosis and treatment of infertility, including IVF for patients who meet clinical criteria. VIOS Fertility Institute works with a broad network of insurance providers and maintains a dedicated financial counseling team to help patients understand their specific benefits.
For patients whose plans do not cover fertility treatment — including those with self-funded ERISA plans that are exempt from the state mandate — VIOS offers financing options through medical lending partners. Multi-cycle packages and shared-risk programs may also be available depending on patient eligibility.
Mandate states: Illinois, New York, New Jersey, Connecticut, Massachusetts, Maryland, and Rhode Island require insurers to cover IVF and related treatments. Residents of these states should confirm mandate applicability with their insurer and employer HR department.
Frequently Asked Questions
Does Illinois insurance cover IVF at VIOS? Illinois law requires most state-regulated group insurance plans to cover infertility treatment, including IVF. However, self-funded employer plans are governed by federal ERISA law and may not be subject to the state mandate. VIOS financial counselors can help you verify your specific plan's coverage before starting treatment.
What is the difference between PGT-A and PGT-M? PGT-A screens embryos for chromosomal abnormalities (extra or missing chromosomes), which are a major cause of failed implantation and miscarriage. PGT-M screens for specific single-gene disorders when one or both partners carries a known genetic mutation, such as BRCA1/2, cystic fibrosis, or spinal muscular atrophy. Your physician will recommend PGT-A, PGT-M, both, or neither based on your history and goals.
How many embryos does VIOS typically transfer? VIOS follows current ASRM guidelines, which generally recommend single-embryo transfer (SET) for most patients to minimize the risk of multiples. The number of embryos transferred is ultimately a shared decision between the patient and physician, taking into account age, embryo quality, and prior treatment history.
Can VIOS help with fertility preservation before cancer treatment? Yes. VIOS offers urgent fertility preservation consultation for patients newly diagnosed with cancer who wish to freeze eggs or embryos before starting chemotherapy or radiation. The clinic coordinates with oncology teams to expedite the process when timing is critical.